Search Results - subject:"Cystic-fibrosis"

Optimal genetic screening for cystic fibrosis

El Hajj, Hussein; Bish, Douglas R.; Bish, Ebru K. - In: Operations research 70 (2022) 1, pp. 265-287

Persistent link: https://www.econbiz.de/10012820656

Cost of Illness of Cystic Fibrosis in Germany: Results from a Large Cystic Fibrosis Centre

Heimeshoff, Mareike; Hollmeyer, Helge; Schreyogg, Jonas … - In: PharmacoEconomics 30 (2012) 9, pp. 763-777

Background:Background: Cystic fibrosis (CF) is the most common life-shortening genetic disorder among Whites worldwide …

Persistent link: https://www.econbiz.de/10011005071

Cost-of-illness analysis and regression modeling in cystic fibrosis : a retrospective prevalence-based study

Mlčoch, Tomáš; Klimeš, Jiří; Fila, Libor; … - In: The European journal of health economics : HEPAC ; … 18 (2017) 1, pp. 73-82

Persistent link: https://www.econbiz.de/10011867991

Staff costs of hospital-based outpatient care of patients with cystic fibrosis

Hollmeyer, Helge; Schreyögg, Jonas; Wahn, Ulrich; … - In: Health Economics Review 1 (2011) 10, pp. 1-8

Background: This study identified per patient resource use and staff costs at a cystic fibrosis (CF) outpatient unit …

Persistent link: https://www.econbiz.de/10010317157

Understanding the costs of care for cystic fibrosis: an analysis by age and severity. CHERE Working Paper 2011/1

Gool, Kees Van; Norman, Richard; Delatycki, Martin B; … - Centre for Health Economics Research & Evaluation … - 2011

Cystic fibrosis (CF) is the most common life-shortening genetic disease, with an incidence of 1 in 2500 and carrier …

Persistent link: https://www.econbiz.de/10010550997

Outpatient Medication Costs of Patients with Cystic Fibrosis in Germany

Eidt-Koch, Daniela; Wagner, Thomas O.F.; Mittendorf, Thomas - In: Applied Health Economics and Health Policy 8 (2010) 2, pp. 111-118

Background: Cystic fibrosis (CF) patients need specialized long-term treatment. In order to support lung function …

Persistent link: https://www.econbiz.de/10008489681

Environmental Toxicology: The Legacy of Silent Spring

Tansey, E.M; Christie, D. A - eSocialSciences - 2009

The authors draws the readerâ€™s attention to the twin toxic hazards that is radiation and chemicals linger , the author effectively fused the pre-existent pollution concerns of urban and industrial reformers to the ecological sensitivities of resource conservation and wilderness...

Persistent link: https://www.econbiz.de/10004965381

Cost of care for Cystic Fibrosis : an investigation of cost determinants using national registry data

Gu, Yuanyuan; García-Pérez, Sonia; Massie, John; Van … - In: The European journal of health economics : HEPAC ; … 16 (2015) 7, pp. 709-717

Persistent link: https://www.econbiz.de/10011482959

Accelerating commercialization: a new model of strategic foundation funding

Feldman, Maryann; Graddy-Reed, Alexandra - In: The Journal of Technology Transfer 39 (2014) 4, pp. 503-523

examine the example of the Cystic Fibrosis Foundation and the development of the drug Kalydeco<Superscript>®</Superscript> as … a demonstration of the principals of strategic foundation funding. The Cystic Fibrosis Foundation adapted to a venture …

Persistent link: https://www.econbiz.de/10010988377

Accelerating commercialization : a new model of strategic foundation funding

Feldman, Maryann P.; Graddy-Reed, Alexandra - In: The journal of technology transfer 39 (2014) 4, pp. 503-523

Persistent link: https://www.econbiz.de/10010382613